MedTrace Logo

Ultrasound-Guided Versus Brainlab Navigation Sphenopalatine Ganglion Block in Functional Endoscopic Sinus Surgery

NCT06984913 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2025-11-25

No results posted yet for this study

Summary

This study compares ultrasound-guided and Brainlab navigation sphenopalatine ganglion block (SPGB) in functional endoscopic sinus surgery (FESS).

Conditions

  • Ultrasound
  • Brainlab Navigation
  • Sphenopalatine Ganglion Block
  • Functional Endoscopic Sinus Surgery

Interventions

OTHER

Ultrasound-guided sphenopalatine ganglion block

Patients will receive an ultrasound-guided sphenopalatine ganglion block (4 ml bupivacaine 0.25%).

OTHER

Brainlab navigation sphenopalatine ganglion block

Patients will receive a Brainlab navigation sphenopalatine ganglion block (4 ml bupivacaine 0.25%).

OTHER

Low dose Brainlab navigation sphenopalatine ganglion block

Patients will receive a Brainlab navigation sphenopalatine ganglion block (2 ml bupivacaine 0.25%) (low dose).

Sponsors & Collaborators

  • Tanta University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-05-22
Primary Completion
2025-10-16
Completion
2025-10-16

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06984913 on ClinicalTrials.gov